Please assess the completion status of the following clinical trial:

Trial Title: Daily Versus Alternate Day Iron Supplementation for the Treatment of Iron Deficiency Anemia in Pregnancy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Hemoglobin less than 11 g/dl in the first trimester or less than 10.5 g/dl in the second trimester~* Microcytic anemia~* Singleton gestation in the first or second trimester~Exclusion Criteria:~* Malabsorptive disorder or history of restrictive or malabsorptive gastric surgery~* Known diagnosis of anemia other than iron deficiency (thalassemia, macrocytic, sickle cell, etc.)~* History of cardiopulmonary disease~* Severe anemia requiring parental infusion or transfusion of blood products

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Study Arms:
- Daily iron supplementation (Type: ACTIVE_COMPARATOR): Oral ferrous sulfate, 325 mg, take once daily
- Alternate day iron supplementation (Type: EXPERIMENTAL): Oral ferrous sulfated, 650mg, taken once daily every other day

Based on this trial design, predict the completion outcome and termination type (if applicable).